624
Views
18
CrossRef citations to date
0
Altmetric
Original article

How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic

, , , , &
Pages 221-228 | Accepted 27 Oct 2014, Published online: 24 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Reina Alameddine, Suzan Seifeddine, Hala Ishak & Jumana Antoun. (2020) Improving statin prescription through the involvement of nurses in the provision of ASCVD score: a quality improvement initiative in primary care. Postgraduate Medicine 132:5, pages 479-484.
Read now
Fotios Barkas, Moses Elisaf, Evangelos Liberopoulos, Rigas Kalaitzidis & George Liamis. (2018) Uric acid and incident chronic kidney disease in dyslipidemic individuals. Current Medical Research and Opinion 34:7, pages 1193-1199.
Read now
Fotios Barkas & Moses Elisaf. (2018) National hyperlipidemia management policies improve lipid target attainment in clinical practice. Current Medical Research and Opinion 34:2, pages 301-303.
Read now

Articles from other publishers (15)

David Pinsdorf, Daniel Messiha, Olga Petrikhovich, Mikail Bahar, Martin Steinmetz, Amir Abbas Mahabadi, Iryna Dykun, Julia Lortz, Tienush Rassaf & Christos Rammos. (2023) Differences in treatment strategies for LDL-cholesterol reduction in a university lipid clinic vs. standard care apart from the use of PCSK9 inhibitors. Journal of Clinical Lipidology.
Crossref
Georgia Anastasiou, Evangelos Liberopoulos, Ermioni Petkou, Amalia Despoina Koutsogianni, Petros Spyridwnas Adamidis, George Liamis, Evangelia Ntzani & Fotios Barkas. (2023) Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin–Therapy: A 6-Year Retrospective Study. Diagnostics 13:3, pages 503.
Crossref
Tania Leme da Rocha Martinez. (2020) Mudanças em Nossos Tempos e nas Metas de Colesterol. Arquivos Brasileiros de Cardiologia 115:3, pages 450-451.
Crossref
Eric Bruckert, Klaus Georg Parhofer, Jose Ramon Gonzalez-Juanatey, Børge Nordestgaard, Marcello Arca, Periklis Giovas & Kausik Ray. (2020) Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review. Advances in Therapy 37:5, pages 1724-1736.
Crossref
Fotios Barkas, Moses Elisaf, Evangelos C. Rizos & Evangelos Liberopoulos. (2019) Bridging the treatment gap in patients at ‘extreme’ cardiovascular risk: Evidence from a lipid clinic. Atherosclerosis 281, pages 216-218.
Crossref
Fotios Barkas, Moses Elisaf & George Liamis. (2019) High-Density Lipoprotein Cholesterol and Hyponatremia: An Unsolved Gordian Knot. The American Journal of Medicine 132:2, pages e47-e48.
Crossref
Boudewijn Klop, Simone C.C. Hartong, Henricus J. Vermeer, Mariette W.C.J. Schoofs & Marcel J.M. Kofflard. (2017) Risk of misclassification with a non-fasting lipid profile in secondary cardiovascular prevention. Clinica Chimica Acta 472, pages 90-95.
Crossref
Fotios Barkas, Moses Elisaf, Panagiotis Korantzopoulos, Stavroula Tsiara & Evangelos Liberopoulos. (2017) The CHADS 2 and CHA 2 DS 2 -VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels. International Journal of Cardiology 241, pages 194-199.
Crossref
Fotios Barkas, Moses Elisaf, Eleftherios Klouras, Theodora Dimitriou, Nikolaos Tentolouris & Evangelos Liberopoulos. (2017) Statin escape phenomenon: Fact or fiction?. World Journal of Experimental Medicine 7:1, pages 25.
Crossref
Dimitrios Alexopoulos, Maria Anastasiou-Nana, Moses S. Elisaf, Evangelos Liberopoulos, Loukianos S. Rallidis, Constantinos H. Davos, Alexandros Moulis, Nikos Nikas, Evangelos Zacharis & Panos Vardas. (2016) A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study. International Journal of Cardiology 217, pages 183-189.
Crossref
Theodosios D. Filippatos & Moses S. Elisaf. (2015) Statin–Ezetimibe Combination Therapy In Diabetic Individuals. Angiology 67:6, pages 507-509.
Crossref
Fotios Barkas, Moses Elisaf, Evangelos Liberopoulos, Angelos Liontos & Evangelos C. Rizos. (2016) High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome. Atherosclerosis 247, pages 58-63.
Crossref
Fotios Barkas, Moses Elisaf, Evangelos Liberopoulos, Eleftherios Klouras, George Liamis & Evangelos C. Rizos. (2016) Statin therapy with or without ezetimibe and the progression to diabetes. Journal of Clinical Lipidology 10:2, pages 306-313.
Crossref
Irtiza Hasan, Tasnuva Rashid & Md. Harun Ur Rashid Bhuiyan. (2016) A Critical Evaluation of the Role of Routine Uses of Statin as a Tool for Primary Prevention of Cardiovascular Diseases. Open Journal of Preventive Medicine 06:04, pages 133-142.
Crossref
Fotios Barkas, Moses Elisaf & Haralampos Milionis. (2015) Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis. Atherosclerosis 243:1, pages 60-64.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.